MyMD Pharmaceuticals Statistics Share Statistics MyMD Pharmaceuticals has 2.37M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 2.37M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) 0.01% Shares Floating 2.11M Failed to Deliver (FTD) Shares 2,850 FTD / Avg. Volume 4.61%
Short Selling Information The latest short interest is 237.7K, so 0% of the outstanding
shares have been sold short.
Short Interest 237.7K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 14.97
Valuation Ratios The PE ratio is -39.74 and the forward
PE ratio is null.
MyMD Pharmaceuticals's PEG ratio is
0.4.
PE Ratio -39.74 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 12.44 P/FCF Ratio -12.25 PEG Ratio 0.4
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for MyMD Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.17,
with a Debt / Equity ratio of 0.
Current Ratio 1.17 Quick Ratio 1.17 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-666.67K Employee Count 6 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 3.43% in the
last 52 weeks. The beta is 2.69, so MyMD Pharmaceuticals's
price volatility has been higher than the market average.
Beta 2.69 52-Week Price Change 3.43% 50-Day Moving Average 1.89 200-Day Moving Average 4.11 Relative Strength Index (RSI) 49.54 Average Volume (20 Days) 61,809
Income Statement
Revenue n/a Gross Profit n/a Operating Income -17.12M Net Income -4M EBITDA -17.12M EBIT n/a Earnings Per Share (EPS) -0.2
Full Income Statement Balance Sheet The company has 2.68M in cash and 48.87K in
debt, giving a net cash position of 2.63M.
Cash & Cash Equivalents 2.68M Total Debt 48.87K Net Cash 2.63M Retained Earnings -101.98M Total Assets 18.78M Working Capital 1.84M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -12.98M
and capital expenditures 0, giving a free cash flow of -12.98M.
Operating Cash Flow -12.98M Capital Expenditures n/a Free Cash Flow -12.98M FCF Per Share -0.63
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields MYMD does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for MYMD.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Feb 15, 2024. It was a
backward
split with a ratio of 1:30.
Last Split Date Feb 15, 2024 Split Type backward Split Ratio 1:30
Scores Altman Z-Score -9.94 Piotroski F-Score 3
